Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations

Cancer Research

Volumn 56, Issue 21, 1996, Pages 4894-4903

  Shibata, Masa Aki ^a   Ward, Jerrold M ^a   Devor, Deborah E ^a   Liu, Min Ling ^a   Green, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS LARGE T ANTIGEN;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; GENE EXPRESSION; GENE MUTATION; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; ONCOGENE H RAS; PRECANCER; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIMIAN VIRUS 40; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL DIVISION; GENES, RAS; MALE; MICE; MICE, TRANSGENIC; MUTATION; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029903593     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Parker, S. L., Tong, T. A., Bolden, S., and Wingo, P. A. Cancer Statistics. CA Cancer J. Clin., 46: 5-27, 1996.
2. Bostwick, D. G., and Brawer, M. K. Prostatic intra- epithelial neoplasia and early invasion in prostate cancer. Cancer (Phila.), 59: 788-794, 1987.
3. Bostwick, D. G. High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer Cancer (Phila.), 75: 1823-1836, 1995.
4. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751-8755, 1990.
5. Bergerheim, U. S. R., Kunimi, K., Collins, V. P., and Ekman, P. Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosomes Cancer, 3: 215-220, 1991.
6. Gao, X., Honn, K. V., Grignon, D., Sakr, W., and Chen, Y. Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas Cancer Res., 53: 2723-2727, 1993.
7. Bova, G. S., Carter, B. S., Bussemarkers, J. G., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., Walsh, P. C., and Isaacs, W. B. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
8. Takahashi, S., Shan, A. L., Ritland, S. R., Delacey, K. A., Bostwick, D. G., Lieber, M. M., Thibodeau, S. N., and Jenkins, R. B. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res., 55: 4114-4119, 1995.
9. Alcaraz, A., Takahashi, S., Brown, J. A., Herath, J. F., Bergstralh, E. J., Larson-Keller, J. J., Lieber, M. M., and Jenkins, R. B. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer Cancer Res., 54: 3998-4002, 1994.
10. Sakr, W. A., Macoska, J. A., Benson, P., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Cnssman, J. D. Allelic loss in locally metastatic, mutisampled prostate cancer. Cancer Res., 54: 3273-3277, 1994.
11. Qian, J., Bostwick, D. G., Takahashi, S., Borell, T. J., Herath, J. F., Lieber, M. M., and Jenkins, R. B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res., 55: 5408-5414, 1995.
12. Emmert-Buck, M. R., Vocke, C. D., Pozzatti, R. O., Duray, P. H., Jennings, S. B., Florence, C. D., Zhuang, Z. Bostwick, D. G., Liotta, L. A., and Linehan, W. M. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res., 55: 2959-2962, 1995.
13. Maroulakou, I. G., Anver, M., Garrett, L., and Green, J. E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl. Acad. Sci. USA, 91: 11236-11240, 1994.
14. Parker, M. G. R., White, H., Hurst, M., Needham, M., and Tilly, R. Prostatic steroid-binding protein: isolation and characterization of C3 genes. J. Biol. Chem., 258: 12-15, 1983.
15. Colombel, M., Symmans, F., Gil, S., O'Toole, K. M., Chopin, D., and Benson, M. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol., 143: 390-400, 1993.
16. Egawa, S., Kadmon, D., Miller, G. J., Scardino, P. T., and Thompson, T. C. Alterations in mRNA levels for growth related genes following transplantation into castrated hosts in oncogene-induced clonal mouse prostate carcinoma. Mol. Carcinog., 5: 52-61, 1992.
17. Truong, L. D., Kadmon, D., McCune, B. K., Flanders, K. C., Scardino, P. T., and Thompson, T. C. Association of transforming growth factor-β1 with prostate cancer: an immunohistochemical study Hum. Pathol., 24: 4-9, 1993.
18. Berges, R. R., Vukanovic, J., Epstein, J. I., CarMichel, M., Cisek, L., Johnson, D. E., Veltri, R. W., Walsh, P. C., and Isaacs, J. T. Implications of the cell kinetic changes during the progression of human prostatic cancer. Clin. Cancer Res., 1: 473-480, 1995.
19. Fox C. H., and Cottler-Fox, M. In situ hybridization in HIV research Microsc. Res. Tech., 25: 78-84, 1993.
20. Orita, M., Youichi, S., Sekiya, T., and Hayashi, K. Rapid sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
21. Ruggeri, B., Caamano, J., Goodrow, T., DiRado, M., Blanchi, D., Trono, D., Conti, C. J., and Klein-Szanto, A. J. P. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression Cancer Res., 51: 6615-6621, 1991.
22. Bostwick, D. G., Amin, M. B., Dundore, P., Marsh, W., and Schultz, D. S. Architectural patterns of high grade prostatic intraepithelial neoplasia Hum. Pathol., 24: 298-310, 1993.
23. Hurst, H. C., and Parker, M. G. Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes EMBO J., 2: 769-774, 1983.
24. Dyson, N., Buchkovich, K., Whyte, P., and Harlow, E. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell, 58: 249-255, 1989.
25. Mietz, J. A., Unger, T., Huibregtse, J. M., and Howley, P. M. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J., 11: 5013-5020, 1992.
26. Shibata, M. A., Maroulakou, I. G., Jorcyk, C. L., Gold, L. G., Ward, J. M., and Green, J. E. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice, suppression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Res., 56: 2998-3003, 1996.
27. Oren, M., Maltzman, W., and Levine, A. J. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol., 1: 101-110, 1981.
28. Reich, N. C., Oren, M., and Levine, A. J. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol. Cell. Biol., 3: 2143-2150, 1983.
29. Montirom, R., Galluzzi, C. M., Diamanti, L., Giannulis, I., Pisani, E., and Scarpelli, M. Prostatic intra-epithehal neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei Virchows Arch. A. Pathol. Anat., 422: 185-192, 1993.
30. Brown, C., Sauvageot, J., Kahane, H., and Epstein, J. I. Cell proliferation and apoptosis in prostate cancer: correlation with pathologic stage? Mod. Pathol., 9: 205-209, 1996.
31. Aihara, M., Truong, L. D., Dunn, J. K., Wheeler, T. M., Scardino, P. T., and Thompson, T. C. Frequency of apoptotic bodies positively correlates with Gleason grade in prostate cancer. Hum. Pathol., 25: 797-801, 1994.
32. Fearon, E. R., and Vogelstein, B. A. genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
33. Carter, B. S., Epstein, J. I., and Isaacs, W. B. RAS gene mutations in human prostate cancer. Cancer Res., 50: 6830-6832, 1990.
34. Gumerlock, P. H., Poonamallee, U. R., Meyers, F. J., and White, W. V. Activated RAS alleles in human carcinoma of the prostate are rare. Cancer Res., 57: 1632-1637, 1991.
35. Moul, J. W., Friedrichs, P. A., Lance, R. S., Theune, S. M., and Chang, E. H. Infrequent ras oncogene mutations in human prostate cancer. Prostate, 20: 327-338, 1992.
36. Konishi, N., Enomoto, T., Buzard, G., Oshima, M., Ward, J. M., and Rice, J. M. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men. Cancer (Phila.), 69: 2293-2299, 1992.
37. Anwar, K., Nakakuki, K., Shiraishi, T., Naiki, H., Yatani, R., and Inuzuka, M. Presence of ras oncogene mutations and human papilloma virus DNA in human prostate carcinomas Cancer Res., 52: 5991-5996, 1992.
38. Watanabe, M., Shiraishi, T., Yatani, R., Nomura, A. M. Y., and Stemmermann, G. N. International comparison on ras gene mutations in latent prostate carcinoma Int. J. Cancer, 58: 174-178, 1994.
39. Thompson, T. C., Southgate, J., Kichener, G., and Land, H. Multicarcinogenesis induced by ras and myc oncogenes in a reconstituted organ Cell, 56: 917-930, 1989.
40. Treiger, B., and Isaacs, J. Expression of a transfected v-Harvey ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability. J. Urol., 140: 1580-1586, 1988.
41. Effert, P. J., Neubauer, A., Walther, P. J., and Liu, E. T. Alterations of the p53 gene are associated with progression of a human prostate carcinoma. J. Urol., 147: 789-793, 1992.
42. Navone, N. M., Troncoso, P., Pisters, L. L., Goodrow, T. L., Palmer, J. L., Nichols, W. W., von Eschenbach, A. C., and Conti, C. J. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma J. Natl. Cancer Inst., 55: 1657-1669, 1993.
43. Effert, P. J., McCoy, R. H., Walther, P. J., and Liu, E. T. p53 gene alterations in human prostate carcinoma. J. Urol., 150: 257-261, 1993.